Cyclin E expression and proliferation in breast cancer.

Area of Science:

• Oncology
• Molecular Biology
• Cell Biology

Background:

• Cyclin E is a key regulator of the cell cycle.
• Aberrant cyclin E expression is observed in various cancers, including breast cancer.
• Understanding cyclin E's role in proliferation is crucial for breast cancer prognosis.

Purpose of the Study:

• To investigate the relationship between cell proliferation and cyclin E expression in breast tumors.
• To identify breast tumors with cyclin E overexpression and assess their clinical significance.

Main Methods:

• Analysis of 74 breast tumors using immunohistochemistry and Western blotting for cyclin E expression.
• Determination of tumor growth fraction using Ki-67 as a marker.
• Flow cytometry analysis of breast cancer cell lines to confirm cell cycle specificity.

Main Results:

• Significant correlations were found between growth fraction (Ki-67) and various measures of cyclin E expression (percentage of positive cells, intensity, total amount).
• Most tumors exhibited cell cycle-specific cyclin E expression, even with inactivated retinoblastoma protein (pRB), indicating pRB-independent regulation.
• A subset of tumors showed elevated cyclin E levels unrelated to proliferation, often associated with high proliferative activity (overexpression).
• High proliferative activity, high total cyclin E, or disproportionately elevated cyclin E relative to proliferation correlated with increased breast cancer mortality risk.

Conclusions:

• Cyclin E expression is generally cell cycle-specific in breast cancer, with some tumors exhibiting overexpression.
• Tumors with high proliferation and elevated cyclin E levels, especially when disproportionate to proliferation, are associated with poor patient survival.
• Immunohistochemical staining intensity for cyclin E did not predict survival, unlike overall levels and proliferation correlation.